Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Cordes

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Journal of the National Cancer Institute|February 10, 2015
Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancerIris Eke, Katja Zscheppang, Ellen Dickreuter, et al.
Biomolecules|April 23, 2020
3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course TreatmentLinas Kunigenas, Vaidotas Stankevicius, Audrius Dulskas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
[Radiotherapy in benign diseases: Morbus Peyronie]Viktor Meineke, Christian Uebler, Frank-Michael Köhn, et al.
The Journal of Clinical Investigation|March 2, 2012
β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyIris Eke, Yvonne Deuse, Stephanie Hehlgans, et al.
Oncotarget|May 18, 2017
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targetingAnne Vehlow, Erik Klapproth, Katja Storch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 6, 2004
Development and evaluation of a skin organ model for the analysis of radiation effectsViktor Meineke, Kerstin Müller, Roland Ridi, et al.
Oncotarget|May 3, 2018
Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibitionErik Klapproth, Ellen Dickreuter, Falk Zakrzewski, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2011
Patterns of widespread decline in North American bumble beesSydney A Cameron, Jeffrey D Lozier, James P Strange, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Journal of the National Cancer Institute|February 10, 2015
Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancerIris Eke, Katja Zscheppang, Ellen Dickreuter, et al.
Biomolecules|April 23, 2020
3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course TreatmentLinas Kunigenas, Vaidotas Stankevicius, Audrius Dulskas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
[Radiotherapy in benign diseases: Morbus Peyronie]Viktor Meineke, Christian Uebler, Frank-Michael Köhn, et al.
The Journal of Clinical Investigation|March 2, 2012
β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyIris Eke, Yvonne Deuse, Stephanie Hehlgans, et al.
Oncotarget|May 18, 2017
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targetingAnne Vehlow, Erik Klapproth, Katja Storch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 6, 2004
Development and evaluation of a skin organ model for the analysis of radiation effectsViktor Meineke, Kerstin Müller, Roland Ridi, et al.
Oncotarget|May 3, 2018
Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibitionErik Klapproth, Ellen Dickreuter, Falk Zakrzewski, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2011
Patterns of widespread decline in North American bumble beesSydney A Cameron, Jeffrey D Lozier, James P Strange, et al.
Pageof 11